
Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trial
08 April 2021
The antiviral drug favipiravir will be investigated as a treatment for COVID-19 in people recovering at home and in other non-hospital settings, in a clinical trial funded and supported by the NIHR.